Table 2.
Fully adjusted models predicting BDEFS scores from SARS-CoV-2 infection status and COVID-19 symptom severity.
| Variable | Frequency | (95% CI) | p |
|---|---|---|---|
| infection status (symptom severity) | |||
| Not infected | 1597 | Ref | Ref |
| Infected (Not at all severe) | 57 | 0.01 (−0.18, 0.21) | 0.881 |
| Infected (Slightly severe) | 46 | 0.11 (−0.17, 0.39) | 0.43 |
| Infected (Moderately severe) | 51 | 0.15 (−0.08, 0.37) | 0.208 |
| Infected (Very severe) | 17 | 0.52 (0.06, 0.98) | 0.026 |
| Infected (Extremely severe) | 4 | 1.13 (0.33, 1.92) | 0.005 |
| Not stated | 128 | −0.05 (−0.22, 0.12) | 0.574 |
| Infected: severity not stated | 7 | 0.49 (−0.20, 1.17) | 0.163 |
| Gender | |||
| Male | 751 | 0.13 (0.06, 0.21) | <0.001 |
| Female | 1156 | Ref | Ref |
| Age group | |||
| 18-24 | 315 | 0.22 (0.11, 0.33) | <0.001 |
| 25-39 | 769 | 0.04 (−0.04, 0.12) | 0.281 |
| 40-54 | 823 | Ref | Ref |
| Income | |||
| Low | 289 | Ref | Ref |
| Moderate | 428 | −0.04 (−0.18, 0.10) | 0.56 |
| High | 1020 | −0.21 (−0.33, −0.09) | <0.001 |
| No answer | 170 | −0.22 (−0.37, −0.06) | 0.006 |
| Geographic Region | |||
| AB | 238 | 0.11 (−0.03, 0.24) | 0.112 |
| BC | 234 | 0.01 (−0.11, 0.14) | 0.819 |
| MB + SK | 117 | 0.16 (−0.02, 0.35) | 0.075 |
| Maritimes | 106 | 0.06 (−0.10, 0.22) | 0.446 |
| ON | 720 | 0.04 (−0.06, 0.15) | 0.409 |
| QC-EN | 129 | 0.11 (−0.04, 0.26) | 0.139 |
| QC-FR | 363 | Ref | Ref |
| Vaccination status | |||
| No shot | 818 | −0.10 (−0.17, −0.02) | 0.015 |
| One shot | 124 | 0.22 (0.04, 0.40) | 0.017 |
| two shots | 965 | Ref | Ref |
| Mitigation behaviour | . | −0.16 (−0.22, −0.10) | <0.001 |
Note: N = 1958; BDEFS=Barkley Deficits in Executive Function Scale; AB = Alberta, BC=British Columbia; MB = Manitoba; SK=Saskatchewan; ON=Ontario; QC = Quebec; Maritimes = Nova Scotia, Prince Edward Island, Newfoundland/Labrador, New Brunswick.